Nom du produit:4-(2-((2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl)thiazol-4-yl)benzonitrile

IUPAC Name:4-{2-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl}benzonitrile

CAS:182760-06-1
Formule moléculaire:C22H17F2N5OS
Pureté:97%
Numéro de catalogue:CM161482
Poids moléculaire:437.47

Unité d'emballage Stock disponible Prix($) Quantité
CM161482-250mg in stock Ǖź
CM161482-1g in stock ƄźȀ
CM161482-5g in stock ŔǕǯ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:182760-06-1
Formule moléculaire:C22H17F2N5OS
Point de fusion:-
Code SMILES:N#CC1=CC=C(C2=CSC([C@@H]([C@@](O)(C3=CC=C(F)C=C3F)CN4N=CN=C4)C)=N2)C=C1
Densité:
Numéro de catalogue:CM161482
Poids moléculaire:437.47
Point d'ébullition:
N° Mdl:MFCD00941002
Stockage:

Category Infos

Thiazoles
Thiazoles are very important functional groups in medicinal chemistry. They act as ligands on a variety of biological matrices. Thiazoles are used in a wide range of therapeutic applications, such as antibacterial, antiretroviral, antifungal, antiallergic, antihypertensive, pain treatment, and to control symptoms of schizophrenia.
Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.